真坑！！！
接种新冠疫苗第一针的时候让装此APP，通过此APP通知接种第二针的时间。下载安装后开始注册，注册时地址是必填项，并且只能选择，但是在选项中没有我所住楼的选项。注册都完成不了的APP，我都懒得吐槽，要不是必须用它接收疫苗接种时间这种重要信息，它在我手机里存在超不过5分钟。
Description
注册用户就是【社区VIP】
享有最炫酷的特权
请向与你此生最近的他，她，他们，道一声好！珍惜上天创造的缘分。
伴儿，一路同行，有你真好！
享有最炫酷的特权
请向与你此生最近的他，她，他们，道一声好！珍惜上天创造的缘分。
伴儿，一路同行，有你真好！
Screenshots
伴儿-低头不见抬头见 FAQ
-
Is 伴儿-低头不见抬头见 free?
Yes, 伴儿-低头不见抬头见 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 伴儿-低头不见抬头见 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 伴儿-低头不见抬头见 cost?
伴儿-低头不见抬头见 is free.
-
What is 伴儿-低头不见抬头见 revenue?
To get estimated revenue of 伴儿-低头不见抬头见 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Chile yet.
Ratings History
伴儿-低头不见抬头见 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
伴儿-低头不见抬头见 Installs
Last 30 days
伴儿-低头不见抬头见 Revenue
Last 30 days伴儿-低头不见抬头见 Revenue and Downloads
Gain valuable insights into 伴儿-低头不见抬头见 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Social Networking
- Publisher
- Beijing Shequ Technology Co
- Languages
- English, Chinese
- Recent release
- 3.3.1106 (1 year ago )
- Released on
- Oct 9, 2020 (4 years ago )
- Also available in
- China, Austria, South Africa, Hungary, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Malaysia, Saudi Arabia, Sweden, Thailand, Türkiye, United States, United Arab Emirates, Indonesia, United Kingdom, Philippines, Pakistan, Chile, Czechia, Germany, Armenia, India, Nepal, Ecuador, Egypt, Algeria, Australia, Azerbaijan, Belgium, Brazil, Nigeria, Russia, Hong Kong SAR China, Switzerland, Denmark, Spain, Finland, France, Greece, Vietnam, Belarus, Canada, Netherlands, Norway, Poland, Peru, Dominican Republic, Romania, Colombia, South Korea, Kuwait, Kazakhstan, Argentina, Lebanon
- Last Updated
- 3 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.